Begin your TipRanks Premium journey today. Longboard Pharmaceuticals (LBPH) Company Description: Longboard Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel ...

Longboard Pharmaceuticals, Inc. ( (LBPH) ) has released its Q3 earnings. Here is a breakdown of the information Longboard Pharmaceuticals, Inc.

Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Free Report) have earned an average rating of “Hold” from the nine ratings firms that are covering the company, MarketBeat.com reports.

On Monday, Longboard Pharmaceuticals Inc (LBPH) stock saw a decline, ending the day at $59.5 which represents a decrease of $-0.19 or -0.32% from the prior close of $59.69. The stock opened at $59.66 ...

On Friday, Longboard Pharmaceuticals Inc (LBPH) stock saw a decline, ending the day at $59.69 which represents a decrease of $-0.03 or -0.05% from the prior close of $59.72. The stock opened at $59.95 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Accelerated growth for strategic brands (+21% CER) drives revenue up 13% CER in the first nine months of 2024 Key highlights Lundbeck's total revenue grew by +13% CER[1] (+10% DKK) to DKK 16,463 milli ...

On Monday, Longboard Pharmaceuticals Inc (NASDAQ: LBPH) saw its price target increased to $36.00 from $30.00, while its stock rating remained a Buy, as announced by a B.Riley ...

Who is ARENA PHARMACEUTICALS INC? ARENA PHARMACEUTICALS INC has an estimated net worth of $96.5 Million. This is based on reported shares in Longboard Pharmaceuticals, Inc.. Attention insiders ...

Longboard Pharmaceuticals Inc. has reached an impressive milestone, with its stock hitting an all-time high of $58.92. This peak reflects a significant surge in investor... ByInvesting.com • Oct ...

NEW YORK, Nov. 12, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches ...